Dear Friends and Colleagues,

We are delighted to announce that the 6th World Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN) will take place on November 07-09, 2019 in Paris, France.

Following the success of previous years’ joint collaboration with the Ovarian Club (OC), the 2019 CoGEN Congress will also take place in conjunction with the Ovarian Club Meeting. Participants registered to one of these meetings will be granted full access to both meetings.

The Faculty: World-renowned scientists and physicians in the field.

The COGEN Congress is a unique educational opportunity for practitioners in the field of human procreation to conduct discussions and network with leading experts.

Read more

CoGEN 2019 Speakers

Slide Alexandra Benachi
France
Slide Lyn Chitty
UK
Slide Rossa Chiu
Hong Kong
Slide Simon Fishel
UK
Slide Darren Griffin
UK
Slide Alan Handyside
UK
Slide Joyce Harper
UK
Slide Avner Hershlag
USA
Slide Eva Hoffman
Denmark
Slide Mark Kilby
UK
Slide Charles Kingsland
UK
Slide Liat Lerner-Geva
Israel
Slide Brynn Levy
USA
Slide Svetlana Madjunkova
Canada
Slide Inmaculada Moreno
Spain
Slide Santiago Munne
Spain
Slide Christian Ottolini
UK
Slide Nathan Treff
USA
Slide Joris Vermeesch
Belgium
Slide Yuval Yaron
Israel
Slide Vincenzo Cirigliano
Spain
View all speakers

Abstract Submission

Submit your abstract until
October 3, 2019

Read more

CoGEN webcasts

View webcasts from previous
CoGEN Congresses

Read more

Support & Exhibition

We invite you to explore our
sponsorship options

Read more

Congress Chairpersons

Simon Fishel

Yuval Yaron

Alexandra Benachi

“Why should I attend?”

COGEN focuses on Innovation in Preconception, Preimplantation and Prenatal Genetic Diagnosis, including:

  • Pre-Congress Courses on Basic Genetic Principles for the Non-Geneticists.
  • Basic research on oocyte aging and the origin of aneuploidy.
  • The use of Next Generation Sequencing for expanded preconception carrier screening.
  • Novel strategies for Non-Invasive Prenatal Testing (NIPT) and Non-invasive Prenatal Diagnosis (NIPD).
  • The use of Whole Exome/Genome Sequencing (WES/WGS) in the evaluation of the malformed fetus.
  • Preimplantation Genetic Testing for Aneuploidy (PGT-A) for detection of chromosome copy number abnormalities in human embryos and oocytes
  • Preimplantation Genetic Testing for monogenic disorders (PGT-M) and structural rearrangements (PGT-SR)
  • Genetic factors in implantation